FEBS Letters · 2006 · 27 citations · 13 references
Life SciencesImmunologyPharmacologyApoptosisChemotherapyInflammationAnti-inflammatory PharmacologyApoptosis ModulationApoptotic SignalingCaspase ActivationEndothelial DysfunctionInflammatory SignalingApoptosis Of Endothelial CellsCaspase-mediated ApoptosisEndothelial ApoptosisIntracellular ExpressionMitochondrial Pathway Of ApoptosisTherapeutic PathwaysTumor Necrosis Factor-mediated Apoptosis
Cyclophosphamide (CPA) is one of the therapeutic agents for systemic inflammatory disorders. In murine dermal endothelial cells (F-2), 4-hydroxycyclophosphamide (4-HC), which is active metabolite of CPA, enhanced TNF-alpha-induced DNA fragmentation. In addition, 4-HC was shown to elevate TNF-alpha-induced caspase-3 activation. Caspase-8 activation was identified by the treatment of TNF-alpha, whereas 4-HC was no effect. In contrast, only when treated with 4-HC, caspase-9 activation and the increase in the intracellular expression of Bax were detected. These results suggest that CPA may sensitize endothelial cells to TNF-alpha-induced apoptosis through a mitochondria-dependent pathway and clinically may contribute to the limitation of inflammatory process.
13
Atan Gross, Xiao Ming Yin, Kun Wang et al. · Journal of Biological Chemistry · 1999 · 1.1K citations · Full text
Pro-caspase-3 Is a Major Physiologic Target of Caspase-8
Henning R. Stennicke, Juliane M. Jürgensmeier, Hwain Shin et al. · Journal of Biological Chemistry · 1998 · 751 citations · Full text
Yuki Hamano, Hikaru Sugimoto, Mary A. Soubasakos et al. · Cancer Research · 2004 · 187 citations · Full text
Medicine, Oncology, Pharmacology +16